Format

Send to

Choose Destination
World J Gastroenterol. 2008 Mar 14;14(10):1570-4.

Mutations in components of the Wnt signaling pathway in gastric cancer.

Author information

1
Department of Cancer Epidemiology, Peking University School of Oncology and Beijing Cancer Hospital & Institute, Beijing, China.

Abstract

AIM:

To explore the contribution of AXIN1, AXIN2 and beta-catenin, components of Wnt signaling pathway, to the carcinogenesis of gastric cancer (GC), we examined AXIN1, AXIN2 exon7 and CTNNB1 (encoding beta-catenin) exon3 mutations in 70 GCs.

METHODS:

The presence of mutations was identified by polymerase chain reaction (PCR)-based denaturing high-performance liquid chromatography and direct DNA sequencing. Beta-catenin expression was detected by immunohistochemical analysis.

RESULTS:

Among the 70 GCs, 5 (7.1%) had mutations in one or two of these three components. A frameshift mutation (1 bp deletion) in exon7 of AXIN2 was found in one case. Four cases, including the case with a mutation in AXIN2, had frameshift mutations and missense mutations in AXIN1. Five single nucleotide polymorphisms (SNPs), 334 C>T, 874 C>T, 1396 G>A, 1690 C>T and 1942 T>G, were identified in AXIN1. A frameshift mutation (27 bp deletion) spanning exon3 of CTNNB1 was observed in one case. All four cases with mutations in AXIN1 and AXIN2 showed nuclear beta-catenin expression.

CONCLUSION:

These data indicate that the mutations in AXIN1 and AXIN2 may contribute to gastric carcino-genesis.

PMID:
18330950
PMCID:
PMC2693754
DOI:
10.3748/wjg.14.1570
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Baishideng Publishing Group Inc. Icon for PubMed Central
Loading ...
Support Center